Proesis Biologics specializes in the collection of human-source plasma through a streamlined donation process that includes health screenings and real-time compensation via a prepaid Mastercard. The company addresses the critical need for plasma-derived therapies by facilitating safe donations while providing donors with immediate financial rewards and convenient appointment management through their mobile app.
Funding
Funding not disclosed
Founders
Product
Problem
Patients requiring plasma-derived therapies often face shortages due to the limited availability of human-source plasma donations. Traditional donation processes can be inconvenient, lacking immediate rewards and streamlined appointment management, which may deter potential donors.
Solution
Proesis Biologics addresses the need for increased plasma donations by providing a streamlined and rewarding donation experience. The company facilitates plasma collection through health screenings and a mobile app for convenient appointment scheduling and management. Donors receive immediate compensation via a reloadable prepaid Mastercard upon their initial donation, offering instant access to their rewards. This approach aims to encourage more frequent donations, ensuring a more stable supply of plasma for critical therapies.
Target Audience
The primary target audience is individuals who are eligible to donate plasma and are motivated by contributing to healthcare and receiving immediate financial compensation.
Features
- Mobile app for scheduling appointments, completing pre-donation questionnaires, and managing rewards
- Real-time payment confirmation and access to funds via the ProesisPlus app or webpage
- Reloadable prepaid Mastercard for immediate compensation after donation
- Loyalty program with enhanced donation fees based on donation frequency
- Referral bonuses for new donors
- PlasmaPoints rewards program redeemable for cash
- Health screenings to ensure donor eligibility and safety